ABSTRACT
Background: The term obstructive airway disorder comprises of bronchial asthma and chronic obstructive airway disease (COPD). Asthma is a chronic inflammatory disorder of airways while COPD is disease of alveoli. Asthma is characterized by recurrent episodes of wheezing, breathlessness, and nocturnal cough while patients of COPD present with chronic progressive breathlessness and wheezing. International guidelines are established for the management of obstructive airway disorders. Aims and Objectives: The aim of the study was to evaluate drug prescribing pattern in bronchial asthma and COPD patients at a tertiary care hospital. Materials and Methods: After obtaining permission from hospital authority and permission from the Institutional Ethics Committee, 54 admitted patients� prescription were screened between period of June 2021 to December 2021. Informed consent taken from the patients and were interviewed for collection of basic data such as name, age, and occupation. The purpose of the observational study was to see whether there is adherence to current practice guidelines of obstructive airway disorders. Data were compiled and tabulated using excel sheet and were presented using percentages and frequencies with necessary graphs and charts. Results: Short acting ?2 agonist (91%) and corticosteroids (59%) were the most prescribed agents in bronchial asthma while corticosteroids (75%) and short acting antimuscarinic agents (78.57%) were most common prescription in COPD patients. The most common antibiotic used for in obstructive airway disease was beta lactam antibiotic-cefotaxime. Conclusion: In obstructive airway disorders, inhalation route was most preferred route as compared to oral, intramuscular, or intravenous route. The preferred antibiotic was cefotaxime.